Fructose-1,6-bisphosphatase Deficiency: What Parents Need to Know
"Early diagnosis through genetic testing can help manage this rare metabolic disorder and prevent serious complications."
Fructose-1,6-bisphosphatase (FBPase) deficiency is a rare, inherited metabolic disorder that disrupts the body's ability to produce glucose from non-carbohydrate sources, a process known as gluconeogenesis. This condition can lead to episodes of low blood sugar (hypoglycemia) accompanied by metabolic and lactic acidosis, which can be frightening for families and require prompt medical intervention.
The original research paper highlights the diagnosis of a Japanese boy with FBPase deficiency, emphasizing the importance of genetic testing and careful management to improve outcomes. Understanding this condition and its genetic underpinnings is crucial for families and healthcare providers alike.
This condition, while rare (affecting 1-9 per 100,000 individuals), is triggered by factors such as fructose intake, fasting, and infections. Once diagnosed, the outlook for children with FBPase deficiency is generally excellent, provided that proper dietary measures and preventive strategies are consistently followed.
Disease Burden and Rarity
Fructose-1,6-bisphosphatase deficiency is an inherited metabolic disorder in which the body cannot properly make glucose, the main blood sugar and a primary energy source for cells. It is inherited in an autosomal recessive manner and results from changes in the FBP1 gene that cause deficiency of the fructose-1,6-bisphosphatase enzyme. Metabolic Support reports that approximately 150 individuals have been affected worldwide; prevalence estimates include 1 in 147,575 people in Italy, 1 in 350,000 in the Netherlands, and less than 1 in 900,000 in France.
Biochemical Foundation
Fructose-1,6-bisphosphatase deficiency is described as a rare autosomal recessive disorder caused by mutations in the FBP1 gene. The disorder impairs the final dephosphorylation step in gluconeogenesis. Medscape identifies fructose-1,6-bisphosphatase as a rate-limiting regulatory enzyme encoded by FBP1 on chromosome 9q22.3; it catalyzes the irreversible hydrolysis of fructose-1,6-bisphosphate to fructose-6-phosphate, enabling endogenous glucose production from amino acids such as alanine and glycine, glycerol, or lactate.
What is Fructose-1,6-Bisphosphatase (FBPase) Deficiency?
FBPase deficiency is caused by mutations in the FBP1 gene, which provides the instructions for making the fructose-1,6-bisphosphatase enzyme. This enzyme plays a vital role in the liver and kidneys, where it helps regulate glucose production. When the enzyme is deficient, the body struggles to maintain stable blood sugar levels, especially during times of fasting or illness.
- Blood Tests: Evaluating pH levels, bicarbonate, lactate, uric acid, glucose, ketone bodies, ammonia, and pyruvate.
- Urine Tests: Analyzing for the presence of lactate and ketone bodies.
- Imaging: CT scans to assess the liver for hepatomegaly and fatty changes.
- Fructose Tolerance Test: Monitoring blood glucose, lactate, and uric acid levels after fructose intake.
- Genetic Testing: Identifying mutations in the FBP1 gene.
Recent Clinical Evidence
A report on severe hypoglycemia and lactic acidosis describes fructose-1,6-bisphosphatase deficiency as an autosomal recessive disorder with an extremely high mortality rate when it remains undiagnosed and untreated. A 2024 report on intrafamilial phenotypic variability found metabolic acidosis in 71 cases, hypoglycemia in 70, vomiting in 46, hyperuricemia in 37, and respiratory distress in 25. Nature and Springer pages dated December 5, 2025, and June 28, 2026, respectively, identify fructose-1,6-bisphosphatase deficiency and metabolic regulation as active research areas.
Diagnostic Testing Limitations
A report of a Japanese boy with a novel FBP1 p.Phe90Val mutation describes a limitation during an oral tolerance test involving a large amount of fructose. The fructose load caused excessive consumption of a derivatizing agent, so urinary glycerol-3-phosphate was not adequately derivatized and could not be detected by GC/MS analysis. This produced insufficient apparent excretion of glycerol-3-phosphate and illustrates how test conditions can affect detection.
Fructose Metabolism Pathways
A 1968 study examined d-fructose metabolism in Aerobacter aerogenes mutants lacking d-fructose 6-phosphate kinase and d-fructose 1,6-diphosphatase. The study compared the consequences of lacking these enzymes within the bacterial pathway. Its data indicated that d-fructose metabolism occurred primarily through d-fructose 1-phosphate rather than d-fructose 6-phosphate.
Looking Ahead: Management and Family Planning
Early diagnosis and management are crucial for individuals with FBPase deficiency. With appropriate dietary control, including limiting fructose and glycerol intake, and prompt treatment of hypoglycemic episodes, affected individuals can lead healthy lives. For families with a child diagnosed with FBPase deficiency, genetic counseling and carrier testing are recommended to assess the risk of recurrence in future pregnancies. This knowledge empowers parents to make informed decisions and prepare for the needs of their children.
Infant Presentation
A case report describes fructose-1,6-bisphosphatase 1 deficiency as a rare autosomal recessive disorder of gluconeogenesis. It reports that affected children can present in infancy with severe hypoglycemia and lactic acidosis. The report concerns a female child aged one year and six months, emphasizing that early childhood presentation may be clinically serious.